Notable Labs Total Current Liabilities 2013-2024 | NTBLQ

Notable Labs total current liabilities from 2013 to 2024. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
Notable Labs Annual Total Current Liabilities
(Millions of US $)
2023 $3
2022 $2
2021 $10
2020 $7
2019 $9
2018 $5
2017 $8
2016 $5
2015 $4
2014 $3
2013 $4
2012 $
Notable Labs Quarterly Total Current Liabilities
(Millions of US $)
2024-06-30 $3
2024-03-31 $3
2023-12-31 $3
2023-09-30 $3
2023-06-30 $5
2023-03-31 $8
2022-12-31 $2
2022-09-30 $10
2022-06-30 $9
2022-03-31 $11
2021-12-31 $10
2021-09-30 $8
2021-06-30 $9
2021-03-31 $7
2020-12-31 $7
2020-09-30 $7
2020-06-30 $7
2020-03-31 $8
2019-12-31 $9
2019-09-30 $8
2019-06-30 $7
2019-03-31 $6
2018-12-31 $5
2018-09-30 $5
2018-06-30 $6
2018-03-31 $8
2017-12-31 $8
2017-09-30 $5
2017-06-30 $6
2017-03-31 $5
2016-12-31 $5
2016-09-30 $4
2016-06-30 $4
2016-03-31 $4
2015-12-31 $4
2015-09-30 $5
2015-06-30 $3
2015-03-31 $3
2014-12-31 $3
2014-09-30 $6
2014-06-30
2014-03-31
2013-12-31 $4
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00
Ocuphire Pharma (IRD) $0.000B 0.00